After scoring a long-awaited FDA approval earlier this month for Rolvedon, Spectrum Pharmaceuticals was hoping to double down with another FDA endorsement for a diffe...

Reports of dwindling COVID-19 vaccine demand have been circulating for months. Now, the slump threatens to cut into BioNTech's revenue hauls in 2022 and beyond, accor...

Over the weekend, Teva revealed plans to finalize its $4.35 billion national opioid settlement by the end of the year and start paying up in 2023, possibly under the ...

Even at a hefty price tag of $2.5 million per treatment, oncoming gene therapies can be the most cost-effective way for patients with hemophilia types A and B to deal...

As part of President Joe Biden’s wide-ranging executive order to bolster U.S. biomanufacturing, the HHS has laid out detailed actions that include regulatory support ...

More than a year after Pfizer and BioNTech brought Biovac into their global vaccine manufacturing network, the South African vaccine producer has made its first batch...

Hanmi Pharmaceutical has relaunched its liver function drug after using its microemulsion technology to improve the absorption rate, thereby addressing a limitation o...

Trilogy Writing & Consulting has been awarded the PIF TICK – the UK’s only assessed quality mark for print and online health and care information. To be awar...

Bayer’s BlueRock Therapeutics has partnered with BioCardia on the delivery of cell therapies, paying a “sizable” upfront fee to access minimally invasive technology t...

As Neurocrine Biosciences grows through U.S. drug launches, the company is simultaneously aiming to expand its global reach with a small buyout. Neurocrine Bio...